SCHEMBL1497330

SCHEMBL1497330

C=C(C)C(=O)CCC(=O)O

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGLN1 Q9GZT9 6/20 0.52
LMNA P02545 4/20 0.52
SLC15A2 Q16348 1/20 0.52
MAPK1 P28482 1/20 0.52
SLC13A3 Q8WWT9 1/20 0.52
OR51E2 Q9H255 1/20 0.52
ALKBH5 Q6P6C2 1/20 0.50
SUCNR1 Q9BXA5 1/20 0.50
PHF8 Q9UPP1 7/20 0.44
KDM2A Q9Y2K7 7/20 0.44
KDM5C P41229 4/20 0.44
KDM4E B2RXH2 3/20 0.44
KDM6B O15054 3/20 0.44
FFAR3 O14843 1/20 0.41
HDAC3 O15379 1/20 0.41
HDAC1 Q13547 1/20 0.41
HDAC2 Q92769 1/20 0.41
HDAC8 Q9BY41 1/20 0.41
SLC22A6 Q4U2R8 1/20 0.38
TSHR P16473 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15759387 0.88 TDP1 (0.44) EGLN1LMNASLC15A2MAPK1SLC13A3
SCHEMBL1497358 0.84 SLC22A6 (0.55) LMNAOR51E2SLC22A6TSHRNFKB1
Succinic Acid SCHEMBL4372083 0.82 LMNA (0.58) EGLN1LMNASLC15A2MAPK1SLC13A3
Succinic Acid SCHEMBL910246 0.82 LMNA (0.58) EGLN1LMNASLC15A2MAPK1SLC13A3
SCHEMBL27849974 0.82 TSHR (0.57) LMNAOR51E2SLC22A6TSHRNFKB1
SCHEMBL9292497 0.82 TSHR (0.57) LMNAOR51E2SLC22A6TSHRNFKB1
Succinic Acid SCHEMBL173955 0.82 LMNA (0.65) EGLN1LMNASLC15A2MAPK1SLC13A3
Succinic Acid SCHEMBL11059037 0.82 LMNA (0.65) EGLN1LMNASLC15A2MAPK1SLC13A3
SCHEMBL23565474 0.82 ACE (0.46) EGLN1LMNASLC15A2MAPK1SLC13A3
Succinic Acid SCHEMBL18604589 0.81 LMNA (0.50) EGLN1LMNASLC15A2MAPK1SLC13A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 98 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118638450-A Medical endoscope antifogging agent and application thereof 辉擎医疗科技(嘉兴)有限公司 2024-09-13 CN claimed
CN-113577395-B Hydrogel artificial blood vessel and preparation method thereof 天津大学(CN) 2023-01-13 CN claimed
CN-113476661-B Composite self-healing artificial blood vessel with three-layer structure and preparation method thereof 中国医学科学院生物医学工程研究所 2022-08-05 CN claimed
US-8883315-B2 Adhesive composition for glass bonding, glass assembly and display using the same DONGWOO FINE-CHEM CO., LTD. (KR) 2014-11-11 US claimed
US-20120308833-A1 ADHESIVE COMPOSITION FOR GLASS BONDING, GLASS ASSEMBLY AND DISPLAY USING THE SAME DONGWOO FINE-CHEM CO., LTD. (KR) 2012-12-06 US claimed
CN-118638450-A Medical endoscope antifogging agent and application thereof 辉擎医疗科技(嘉兴)有限公司 2024-09-13 CN disclosed
US-20240157679-A1 GLASS LAMINATE ARTICLE AND ADHESIVE COMPOSITION FOR THE SAME CORNING INCORPORATED 2024-05-16 US disclosed
WO-2024096482-A1 ADHESIVE COMPOSITION, ADHESIVE SHEET MANUFACTURED THEREFROM, AND IMAGE DISPLAY DEVICE 동우화인켐 주식회사 2024-05-10 WO disclosed
US-20240150600-A1 INK DIC CORPORATION (JP) 2024-05-09 US disclosed
US-11976223-B2 Adhesive composition, adhesive sheet and image display device prepared from the same DONGWOO FINE-CHEM CO., LTD. (KR) 2024-05-07 US disclosed
WO-2024048585-A1 RUBBER-BONDED CELLULOSE FIBERS AND MANUFACTURING METHOD THEREFOR, RESIN COMPOSITION AND MANUFACTURING METHOD THEREFOR, AND CURABLE RESIN COMPOSITION 株式会社クレハ 2024-03-07 WO disclosed
EP-4308379-A1 GLASS LAMINATE ARTICLE AND ADHESIVE COMPOSITION FOR THE SAME Corning Incorporated (US) 2024-01-24 EP disclosed
CN-102443102-A Liquid film-forming material and synthesis method thereof SHAOSHENG DONG 2012-05-09 CN disclosed
US-20110230476-A1 PI3 KINASE INHIBITORS AND USES THEREOF AVILA THERAPEUTICS, INC. (US) 2011-09-22 US disclosed
EP-2322354-A1 INKJET ACCEPTING AGENT FOR OILY PIGMENT INK, INKJET RECORDING MEDIUM FOR OILY PIGMENT INK AND PRINTED ARTICLE DIC Corporation (JP) 2011-05-18 EP disclosed
US-20110104405-A1 Inkjet receiving agent for oil-based pigment ink, inkjet recording medium for oil based pigment ink, and printed material DIC CORPORATION (JP) 2011-05-05 US disclosed
WO-2011031896-A2 PI3 KINASE INHIBITORS AND USES THEREOF AVILA THERAPEUTICS, INC. (US) 2011-03-17 WO disclosed
US-20100163166-A1 Antistatic adhesive composition, adhesive film using the same, method for producing the adhesive film, and method of fabricating liquid crystal display Wuxi Hengxin Optoelectronic Materials Co., Ltd. (CN) 2010-07-01 US disclosed
US-6048924-A AMINO RESIN FROM CARBOXY AMINO COMPOUND BENZOGUANIMINE DAINIPPON INK AND CHEMICALS, INC. (JP) 2000-04-11 US disclosed
EP-0860473-A1 AQUEOUS RESIN COMPOSITION AND AQUEOUS PAINT DAINIPPON INK AND CHEMICALS, INC. (JP) 1998-08-26 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110230476-A1 PI3 KINASE INHIBITORS AND USES THEREOF PIK3CA, PIK3CB, PIK3C2B EGLN1 2090/4885LMNA 3776/4885SLC15A2 4836/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.